Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Hot Flashes 5Breast Neoplasms 4Prostatic Neoplasms 2Head and Neck Neoplasms 2Depression 2Stage III Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8 1Sleep Wake Disorders 1Lymphoma, Follicular 1Depressive Disorder, Major 1Depressive Disorder 1Carcinoma, Lobular 1Carcinoma, Intraductal, Noninfiltrating 1Breast Carcinoma In Situ 1Bipolar Disorder 1

Interventions

Tamoxifen 16Radiotherapy 9Anastrozole 8Letrozole 7Chemotherapy, Adjuvant 7Specimen Handling 6Radiation 5Neoadjuvant Therapy 5Mastectomy, Segmental 5Biopsy 5Sentinel Lymph Node Biopsy 4Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Gene Expression Profiling 4Early Intervention, Educational 4Counseling 4exemestane 3afimoxifene 3Surveys and Questionnaires 3Surgical Procedures, Operative 3Methods 3Mastectomy 3Magnetic Resonance Spectroscopy 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3pasireotide 2Trastuzumab 2Standard of Care 2Soybean Proteins 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Carcinoma, Intraductal, Noninfiltrating × Venlafaxine Hydrochloride × Clear all
NCT00084669 2010-04-28

Venlafaxine With or Without Zolpidem in Treating Hot Flashes and Associated Sleep Disorders in Women With Breast Cancer OR at High Risk for Developing Breast Cancer

Massachusetts General Hospital

Phase NA Completed
119 enrolled
Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Sleep Wake Disorders, Carcinoma, Lobular, Hot Flashes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡